SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-067967 from BAIYU Holdings, Inc. (BYU) (CIK 0001556266)

BAIYU Holdings, Inc. (BYU) (CIK 0001556266)
Date: Aug. 16, 2023 · CIK: 0001556266 · Accession: 0001213900-23-067967

AI Filing Summary & Sentiment

File numbers found in text: 001-36055

Date
Aug. 16, 2023
Author
/s/ Yue (Mark) Li
Form
CORRESP
Company
BAIYU Holdings, Inc. (BYU) (CIK 0001556266)

Letter

Division of Corporation Finance Office of Life Sciences Re: TD Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 10, 2023 SEC File No.: 001-36055

Dear Sir/Madam,

On behalf of TD Holdings, Inc. (the “Company”), we set forth below responses to the comment letter of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) dated as of August 8, 2023 with respect to the Company’s Annual Report on Form 10-K for the Fiscal Year ended December 31, 2022 (File No. 001-36055) filed with the Commission on March 10, 2023 (the “2022 Form 10-K”).

In response to the Staff’s comment, we respectively note that Item 101(g) of Regulation S-K does not apply to the Company as it is not a foreign private issuer. However, we note that the Company has indicated in its response to the Staff’s initial comment letter that it intends to add in its future filings certain disclosure that should be materially consistent with the substance of Item 101(g).

Thank you for your consideration in reviewing the above responses. If you have any questions or wish to discuss any aspect of the 2022 Form 10-K, please contact the undersigned at markli@magstonelaw.com.

Very truly yours,
/s/ Yue (Mark) Li

Show Raw Text
CORRESP
1
filename1.htm

    WWW.MAGSTONELAW.COM

    293
                           Eisenhower

                           Parkway Suite 135

    Livingston
    NJ 07039

    415
                           S Murphy Ave

    Sunnyvale

    Ca
    94086

    1180
                           Avenue of the

                           Americas
                           8th Floor

    New York, NY
    10036

    1
                           Raffles Place -

                           Tower
2, #20-61

                           Singapore
048616

August
16, 2023

Division
of Corporation Finance Office of Life Sciences

U.S.
Securities and Exchange Commission

100
F Street, NE

Washington,
DC 20549

    Re:
    TD Holdings,
    Inc.

    Form 10-K for
    the Fiscal Year Ended December 31, 2022

    Filed March
    10, 2023

    SEC File No.:
    001-36055

Dear
Sir/Madam,

On
behalf of TD Holdings, Inc. (the “Company”), we set forth below responses to the comment letter of the staff (the
“Staff”) of the Securities and Exchange Commission (the “Commission”) dated as of August 8, 2023
with respect to the Company’s Annual Report on Form 10-K for the Fiscal Year ended December 31, 2022 (File No. 001-36055) filed
with the Commission on March 10, 2023 (the “2022 Form 10-K”).

In
response to the Staff’s comment, we respectively note that Item 101(g) of Regulation S-K does not apply to the Company as it is
not a foreign private issuer. However, we note that the Company has indicated in its response to the Staff’s initial comment letter
that it intends to add in its future filings certain disclosure that should be materially consistent with the substance of Item 101(g).

Thank you for your
consideration in reviewing the above responses. If you have any questions or wish to discuss any aspect of the 2022 Form 10-K, please
contact the undersigned at markli@magstonelaw.com.

    Very truly yours,

    /s/ Yue (Mark) Li

    Yue (Mark) Li